Berenberg lowered the firm’s price target on Sanofi (SNY) to EUR 118 from EUR 120 and keeps a Buy rating on the shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNY:
- Oppenheimer bullish on Nurix as Sanofi opt-in, competitor data derisk STAT6
- Sanofi price target lowered to EUR 108 from EUR 121 at Guggenheim
- Morning Movers: Trump to bump steel tariffs, pharma companies announce deals
- Sanofi acquisition of Blueprint Medicines ‘sensible,’ says BofA
- Sanofi exercises license extension option to Nurix’s STAT6 program
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue